Cover Image
市場調查報告書

歐洲的靜脈通路裝置·配件市場

European Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite

出版商 iData Research Inc. 商品編碼 601847
出版日期 內容資訊 英文 1206 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的靜脈通路裝置·配件市場 European Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite
出版日期: 2016年10月01日 內容資訊: 英文 1206 Pages
簡介

本報告提供歐洲的靜脈通路裝置·配件市場相關調查分析,提供市場概要,趨勢分析,推動市場要素與阻礙要素,競爭分析等系統性資訊。

摘要整理

歐洲的靜脈通路裝置·配件市場概要

競爭分析

市場趨勢

市場發展

對象市場

主要的調查更新

版本履歷

第1章 調查手法

第2章 疾病概要

  • 基本結構
    • 人的血管系統
  • 血管病變·障礙
    • 癌症
    • 末期腎功能衰竭
    • 糖尿病

第3章 產品的評估

第4章 歐洲的靜脈通路裝置·配件市場概要

  • 簡介
  • 匯率
  • 市場概要
  • 趨勢分析
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析
  • 企業簡介
  • SWOT分析
  • M&A

第5章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 斯堪地那維亞各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第6章 治療數量

第7章 置入式埠口市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第8章 Port Needle市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第9章 中央靜脈導管 (CVC) 市場

  • 簡介
  • 單位分析
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第10章 末梢穿刺中央靜脈導管 (PICC) 市場

  • 簡介
  • 單位分析
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第11章 週邊靜脈導管 (PIVC) 市場

  • 簡介
  • 單位分析
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第12章 透析用導管市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第13章 導管固定器具市場

  • 簡介
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第14章 注射器及注射針市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

附錄

簡稱

目錄
Product Code: iDATA_EUVA17_MS

The full report suite on the European market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), dialysis catheters, manufactured catheter securement devices (MCSDs) and syringes and needles. Vascular access devices are used for gaining access to a patient's bloodstream via the veins. They can deliver a wide range of treatments, including fluid infusion, blood draws, parenteral nutrition, antibiotics, chemotherapy and dialysis. The duration of treatment lasts anywhere from hours to years, depending on the type of vascular access device used and the type of medication that is being infused.

Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 have been transposed in all countries included in this report. In addition, regions in Europe have passed their own laws to promote the use of safety devices such as syringes and needles in the workplace. Safety products carry a significant price premium compared to conventional products; the higher ASPs of these safety devices have increased the value of the market, and ongoing conversion is expected to boost future growth. While the conversion to the use of safety needles and PIVCs is taking place in Europe following the introduction of the directive by the Council of the European Union, lack of enforcement by local authorities will hinder the conversion to safety devices. In 2016, it was estimated that approximately 90% of patients who were hospitalized in the Western European region received vascular access treatment during their stay. The ability to infuse medications or fluids into a patient's bloodstream is indispensable to modern medicine. Vascular access devices include peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, Huber needles, dialysis catheters, manufactured catheter securement devices and syringes and needles. The European market for vascular access devices and accessories includes Germany, France, Italy, the United Kingdom, Spain, Benelux (the Netherlands, Belgium and Luxembourg), Scandinavia (Sweden, Norway, Denmark and Finland), Portugal, Austria and Switzerland.

Table of Contents

EUROPEAN VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 278

  • 4.1 INTRODUCTION 278
  • 4.2 CURRENCY EXCHANGE RATE 279
  • 4.3 MARKET OVERVIEW 280
  • 4.4 TREND ANALYSIS 286
  • 4.5 DRIVERS AND LIMITERS 289
    • 4.5.1 Market Drivers 289
    • 4.5.2 Market Limiters 291
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 293
  • 4.7 COMPANY PROFILES 297
    • 4.7.1 AngioDynamics 297
    • 4.7.2 B. Braun 298
    • 4.7.3 Becton Dickinson 298
    • 4.7.4 C. R. Bard 299
    • 4.7.5 Medcomp 300
    • 4.7.6 Medtronic 300
    • 4.7.7 Smiths Medical 302
    • 4.7.8 Teleflex 303
    • 4.7.9 Terumo 304
  • 4.8 SWOT ANALYSIS 305
    • 4.8.1 B. Braun 305
    • 4.8.2 Becton Dickinson 306
    • 4.8.3 C.R. Bard 307
    • 4.8.4 Medtronic 308
    • 4.8.5 Smiths Medical 309
    • 4.8.6 Teleflex 310
    • 4.8.7 Terumo 311
  • 4.9 MERGERS AND ACQUISITIONS 312

COUNTRY PROFILES 317

  • 5.1 INTRODUCTION 317
    • 5.1.1 Population 317
    • 5.1.2 GDP Per Capita 317
    • 5.1.3 Price Index 317
  • 5.2 GERMANY 318
  • 5.3 FRANCE 319
  • 5.4 UNITED KINGDOM 320
  • 5.5 ITALY 321
  • 5.6 SPAIN 322
  • 5.7 BENELUX 323
  • 5.8 SCANDINAVIA 324
  • 5.9 AUSTRIA 325
  • 5.10 SWITZERLAND 326
  • 5.11 PORTUGAL 327

PROCEDURE NUMBERS 328

  • 6.1 TOTAL VASCULAR ACCESS PROCEDURES 328
  • 6.2 IMPLANTABLE PORT PROCEDURES 331
  • 6.3 PORT NEEDLE PROCEDURES 334
  • 6.4 CVC PROCEDURES 337
  • 6.5 PICC PROCEDURES 340
  • 6.6 PIVC PROCEDURES 343
  • 6.7 DIALYSIS CATHETER PROCEDURES 346
  • 6.8 ULTRASOUND VASCULAR ACCESS PROCEDURES 353

IMPLANTABLE PORT MARKET 355

  • 7.1 INTRODUCTION 355
    • 7.1.1 Implantable Port Patients 355
    • 7.1.2 Port Implantation Procedures 356
    • 7.1.3 Port Infusion 356
    • 7.1.4 Port Maintenance 357
    • 7.1.5 Power Ports 357
  • 7.2 MARKET OVERVIEW 358
  • 7.3 MARKET ANALYSIS AND FORECAST 362
    • 7.3.1 Total Implantable Port Market 362
    • 7.3.2 Conventional Implantable Port Market 370
      • 7.3.2.1 Single-Lumen Conventional Implantable Port Market 377
      • 7.3.2.2 Double-Lumen Conventional Implantable Port Market 379
    • 7.3.3 Power-Injectable Implantable Port Market 381
      • 7.3.3.1 Single-Lumen Power-Injectable Implantable Port Market 388
      • 7.3.3.2 Double-Lumen Power-Injectable Implantable Port Market 390
  • 7.4 DRIVERS AND LIMITERS 392
    • 7.4.1 Market Drivers 392
    • 7.4.2 Market Limiters 393
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 396

PORT NEEDLE MARKET 401

  • 8.1 INTRODUCTION 401
    • 8.1.1 Safety Port Needles 401
    • 8.1.2 Power-Injectable Port Needles 402
  • 8.2 MARKET OVERVIEW 403
  • 8.3 MARKET ANALYSIS AND FORECAST 407
    • 8.3.1 Total Port Needle Market 407
    • 8.3.2 Conventional Port Needle Market 415
    • 8.3.3 Safety Port Needle Market 422
      • 8.3.3.1 Power-Injectable Safety Port Needle Market 429
      • 8.3.3.2 Non-Power-Injectable Safety Port Needle Market 436
  • 8.4 DRIVERS AND LIMITERS 443
    • 8.4.1 Market Drivers 443
    • 8.4.2 Market Limiters 443
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 445

CENTRAL VENOUS CATHETER MARKET 449

  • 9.1 INTRODUCTION 449
    • 9.1.1 CVC Procedures 450
    • 9.1.2 CVC Kits 450
    • 9.1.3 CVC Market Segments 451
    • 9.1.4 Antimicrobial CVCs 451
    • 9.1.5 Multi-Lumen CVCs 452
    • 9.1.6 Chronic CVCs 452
  • 9.2 UNIT ANALYSIS 454
      • 9.2.1.1 Acute CVC Units Sold by Patient Type 454
  • 9.3 MARKET OVERVIEW 456
  • 9.4 MARKET ANALYSIS AND FORECAST 460
    • 9.4.1 Total Central Venous Catheter Market 460
    • 9.4.2 Total Acute Central Venous Catheter Market 468
      • 9.4.2.1 Conventional Acute Central Venous Catheter Market 475
      • 9.4.2.2 Antimicrobial Acute Central Venous Catheter Market 482
    • 9.4.3 Chronic Central Venous Catheter Market 489
  • 9.5 DRIVERS AND LIMITERS 496
    • 9.5.1 Market Drivers 496
    • 9.5.2 Market Limiters 497
  • 9.6 COMPETITIVE MARKET SHARE ANALYSIS 499

PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 508

  • 10.1 INTRODUCTION 508
    • 10.1.1 PICC Placement 508
    • 10.1.2 Catheter Material 509
    • 10.1.3 Power-Injectable PICCs 510
  • 10.2 UNIT ANALYSIS 511
      • 10.2.1.1 Peripherally Inserted Central Catheter Units Sold by Lumen Number 511
  • 10.3 MARKET OVERVIEW 513
  • 10.4 MARKET ANALYSIS AND FORECAST 517
    • 10.4.1 Total Peripherally Inserted Central Catheter Market 517
    • 10.4.2 Conventional Peripherally Inserted Central Catheter Market 525
    • 10.4.3 Power-Injectable Peripherally Inserted Central Catheter Market 532
  • 10.5 DRIVERS AND LIMITERS 539
    • 10.5.1 Market Drivers 539
    • 10.5.2 Market Limiters 540
  • 10.6 COMPETITIVE MARKET SHARE ANALYSIS 543

PERIPHERAL INTRAVENOUS CATHETER MARKET 548

  • 11.1 INTRODUCTION 548
    • 11.1.1 Safety PIVCs 549
      • 11.1.1.1 Blood Control Safety PIVCs 549
      • 11.1.1.2 Non-Blood Control Safety PIVCs 549
      • 11.1.1.2.1 Active Safety PIVCs 550
      • 11.1.1.2.2 Passive Safety PIVCs 550
  • 11.2 UNIT ANALYSIS 551
      • 11.2.1.1 Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism 551
  • 11.3 MARKET OVERVIEW 553
  • 11.4 MARKET ANALYSIS AND FORECAST 558
    • 11.4.1 Total Peripheral Intravenous Catheter Market 558
    • 11.4.2 Conventional Peripheral Intravenous Catheter Market 566
    • 11.4.3 Total Safety Peripheral Intravenous Catheter Market 573
      • 11.4.3.1 Active Safety Peripheral Intravenous Catheter Market 580
      • 11.4.3.2 Passive Safety Peripheral Intravenous Catheter Market 588
      • 11.4.3.3 Integrated Blood Control Safety Peripheral Intravenous Catheter Market 595
    • 11.4.4 Total Midline Catheter Market 602
      • 11.4.4.1 Conventional Midline Catheter Market 604
      • 11.4.4.2 Power-Injectable Midline Catheter Market 606
      • 11.4.4.3 All-In-One Midline Catheter Market 608
  • 11.5 DRIVERS AND LIMITERS 610
    • 11.5.1 Market Drivers 610
    • 11.5.2 Market Limiters 612
  • 11.6 COMPETITIVE MARKET SHARE ANALYSIS 615

DIALYSIS CATHETER MARKET 619

  • 12.1 INTRODUCTION 619
    • 12.1.1 Hemodialysis Catheters 619
    • 12.1.2 Acute Hemodialysis Catheters 620
    • 12.1.3 Chronic Hemodialysis Catheters 620
    • 12.1.4 Peritoneal Dialysis 621
    • 12.1.5 AV Fistulae 621
    • 12.1.6 AV Grafts 622
  • 12.2 MARKET OVERVIEW 623
  • 12.3 MARKET ANALYSIS AND FORECAST 627
    • 12.3.1 Total Dialysis Catheter Market 627
    • 12.3.2 Acute Hemodialysis Catheter Market 635
    • 12.3.3 Total Chronic Hemodialysis Catheter Market 643
      • 12.3.3.1 Conventional Chronic Hemodialysis Catheter Market 651
      • 12.3.3.2 Antimicrobial Chronic Hemodialysis Catheter Market 658
    • 12.3.4 Peritoneal Dialysis Catheter Market 666
  • 12.4 DRIVERS AND LIMITERS 669
    • 12.4.1 Market Drivers 669
    • 12.4.2 Market Limiters 669
  • 12.5 COMPETITIVE MARKET SHARE ANALYSIS 671

CATHETER SECUREMENT DEVICE MARKET 682

  • 13.1 INTRODUCTION 682
    • 13.1.1 Catheter Stabilization Methods 683
      • 13.1.1.1 Tape and Dressings 683
      • 13.1.1.2 Manufactured Catheter Securement Devices 683
      • 13.1.1.3 Sutures 684
  • 13.2 MARKET ANALYSIS AND FORECAST 685
  • 13.3 DRIVERS AND LIMITERS 694
    • 13.3.1 Market Drivers 694
    • 13.3.2 Market Limiters 694
  • 13.4 COMPETITIVE MARKET SHARE ANALYSIS 696

SYRINGE AND NEEDLE MARKET 700

  • 14.1 INTRODUCTION 700
    • 14.1.1 Two-Part and Three-Part Syringes 701
    • 14.1.2 Safety Devices 701
    • 14.1.3 Insulin Syringes 702
  • 14.2 MARKET OVERVIEW 703
  • 14.3 MARKET ANALYSIS AND FORECAST 707
    • 14.3.1 Total Syringe and Needle Market 707
    • 14.3.2 Total Syringe Market 715
      • 14.3.2.1 Total Conventional Syringe Market 723
      • 14.3.2.1.1 Two-Part Conventional Syringe Market 731
      • 14.3.2.1.2 Three-Part Conventional Syringe Market 739
      • 14.3.2.2 Safety Syringe Market 747
      • 14.3.2.3 Total Insulin Syringe Market 755
      • 14.3.2.3.1 Insulin Syringe with Needle Market 763
      • 14.3.2.3.2 Insulin Syringe without Needle Market 765
    • 14.3.3 Total Needle Market 767
      • 14.3.3.1 Conventional Needle Market 775
      • 14.3.3.2 Safety Needle Market 783
      • 14.3.3.3 Blunt Type Needle Market 791
  • 14.4 DRIVERS AND LIMITERS 793
    • 14.4.1 Market Drivers 793
    • 14.4.2 Market Limiters 794
  • 14.5 COMPETITIVE MARKET SHARE ANALYSIS 797

APPENDIX I: VASCULAR ACCESS ULTRASOUND MARKET 803

  • 15.1 MARKET ANALYSIS AND FORECAST 803
    • 15.1.1 Vascular Access Ultrasound System Market 803
    • 15.1.2 Tip-Placement System and Accessories Market 807

ABBREVIATIONS 809

LIST OF CHARTS

  • Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 - 2023 2
  • Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023 2
  • Chart 3 1: Male Incidence, Digestive Cancer, U.S., 2016 34
  • Chart 3 2: Male Deaths, Digestive Cancer, U.S., 2016 34
  • Chart 3 3: Female Incidence, Digestive Cancer, U.S., 2016 35
  • Chart 3 4: Female Deaths, Digestive Cancer, U.S., 2016 35
  • Chart 3 5: Male Incidence, Genital Cancer, U.S., 2016 37
  • Chart 3 6: Male Deaths, Genital Cancer, U.S., 2016 37
  • Chart 3 7: Female Incidence, Genital Cancer, U.S., 2016 38
  • Chart 3 8: Female Deaths, Genital Cancer, U.S., 2016 38
  • Chart 3 9: Incidence by Gender, Breast Cancer, U.S., 2016 40
  • Chart 3 10: Deaths by Gender, Breast Cancer, U.S., 2016 40
  • Chart 3 11: Male Incidence, Respiratory Cancer, U.S., 2016 42
  • Chart 3 12: Male Deaths, Respiratory Cancer, U.S., 2016 42
  • Chart 3 13: Female Incidence, Respiratory Cancer, U.S., 2016 43
  • Chart 3 14: Female Deaths, Respiratory Cancer, U.S., 2016 43
  • Chart 3 15: Male Incidence, Urinary Cancer, U.S., 2016 45
  • Chart 3 16: Male Deaths, Urinary Cancer, U.S., 2016 45
  • Chart 3 17: Female Incidence, Urinary Cancer, U.S., 2016 46
  • Chart 3 18: Female Deaths, Urinary Cancer, U.S., 2016 46
  • Chart 3 19: Male Incidence, Skin Cancer, U.S., 2016 48
  • Chart 3 20: Male Deaths, Skin Cancer, U.S., 2016 48
  • Chart 3 21: Female Incidence, Skin Cancer, U.S., 2016 49
  • Chart 3 22: Female Deaths, Skin Cancer, U.S., 2016 49
  • Chart 3 23: Male Incidence, Lymphoma Cancer, U.S., 2016 51
  • Chart 3 24: Male Deaths, Lymphoma Cancer, U.S., 2016 51
  • Chart 3 25: Female Incidence, Lymphoma Cancer, U.S., 2016 52
  • Chart 3 26: Female Deaths, Lymphoma Cancer, U.S., 2016 52
  • Chart 3 27: Male Incidence, Endocrine Cancer, U.S., 2016 54
  • Chart 3 28: Male Deaths, Endocrine Cancer, U.S., 2016 54
  • Chart 3 29: Female Incidence, Endocrine Cancer, U.S., 2016 55
  • Chart 3 30: Female Deaths, Endocrine Cancer, U.S., 2016 55
  • Chart 3 31: Male Incidence, Leukemia Cancer, U.S., 2016 57
  • Chart 3 32: Male Deaths, Leukemia Cancer, U.S., 2016 57
  • Chart 3 33: Female Incidence, Leukemia Cancer, U.S., 2016 58
  • Chart 3 34: Female Deaths, Leukemia Cancer, U.S., 2016 58
  • Chart 3 35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2016 60
  • Chart 3 36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2016 60
  • Chart 3 37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2016 61
  • Chart 3 38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2016 61
  • Chart 3 39: Incidence by Gender, Myeloma Cancer, U.S., 2016 63
  • Chart 3 40: Deaths by Gender, Myeloma Cancer, U.S., 2016 63
  • Chart 3 41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2016 65
  • Chart 3 42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2016 65
  • Chart 3 43: Incidence by Gender, Soft Tissue Cancer, U.S., 2016 67
  • Chart 3 44: Deaths by Gender, Soft Tissue Cancer, U.S., 2016 67
  • Chart 3 45: Incidence by Gender, Bone and Joint Cancers, U.S., 2016 69
  • Chart 3 46: Deaths by Gender, Bone and Joint Cancers, U.S., 2016 69
  • Chart 3 47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2016 71
  • Chart 3 48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2016 71
  • Chart 3 49: End-Stage Renal Disease Incident Cases, U.S., 1996 - 2015 74
  • Chart 3 50: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 - 2015 76
  • Chart 3 51: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 - 2015 78
  • Chart 3 52: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015 80
  • Chart 3 53: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 - 2015 82
  • Chart 3 54: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 - 2014 83
  • Chart 3 55: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 - 2015 87
  • Chart 3 56: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 - 2015 89
  • Chart 3 57: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 - 2015 91
  • Chart 3 58: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 - 2015 93
  • Chart 3 59: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015 96
  • Chart 3 60: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 - 2015 99
  • Chart 3 61: Diagnosed Diabetes Prevalence Count Adults, U.S., 1997 - 2015 104
  • Chart 4 1: Central Venous Catheter Market Segments, 2015 123
  • Chart 2 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 - 2023 284
  • Chart 2 2: Vascular Access Device and Accessories Market Breakdown, Europe, 2016 285
  • Chart 2 3: Vascular Access Device and Accessories Market Breakdown, Europe, 2023 285
  • Chart 2 4: Growth Rates by Segment, Vascular Access Device and Accessories Market, Europe, 2013 - 2023 288
  • Chart 2 5: Leading Competitors, Vascular Access Device and Accessories Market, Europe, 2016 296
  • Chart 3 1: Country Profile, Germany, 2016 318
  • Chart 3 2: Country Profile, France, 2016 319
  • Chart 3 3: Country Profile, United Kingdom, 2016 320
  • Chart 3 4: Country Profile, Italy, 2016 321
  • Chart 3 5: Country Profile, Spain, 2016 322
  • Chart 3 6: Country Profile, Benelux, 2016 323
  • Chart 3 7: Country Profile, Scandinavia, 2016 324
  • Chart 3 8: Country Profile, Austria, 2016 325
  • Chart 3 9: Country Profile, Switzerland, 2016 326
  • Chart 3 10: Country Profile, Portugal, 2016 327
  • Chart 4 1: Implantable Port Insertion Procedures, Europe, 2013 - 2023 333
  • Chart 4 2: Port Needle Insertion Procedures, Europe, 2013 - 2023 336
  • Chart 4 3: CVC Insertion Procedures, Europe, 2013 - 2023 339
  • Chart 4 4: PICC Insertion Procedures, Europe, 2013 - 2023 342
  • Chart 4 5: PIVC Insertion Procedures, Europe, 2013 - 2023 345
  • Chart 4 6: Dialysis Catheter Insertion Procedures by Type, Europe, 2013 - 2023 352
  • Chart 4 7: Ultrasound Vascular Access Procedures, Europe, 2016 354
  • Chart 5 1: Implantable Port Market by Segment, Europe, 2013 - 2023 360
  • Chart 5 2: Implantable Port Market Breakdown, Europe, 2016 361
  • Chart 5 3: Implantable Port Market Breakdown, Europe, 2023 361
  • Chart 5 4: Total Implantable Port Market, Europe, 2013 - 2023 364
  • Chart 5 5: Conventional Implantable Port Market, Europe, 2013 - 2023 371
  • Chart 5 6: Single-Lumen Conventional Implantable Port Market, Europe, 2013 - 2023 378
  • Chart 5 7: Double-Lumen Conventional Implantable Port Market, Europe, 2013 - 2023 380
  • Chart 5 8: Power-Injectable Implantable Port Market, Europe, 2013 - 2023 382
  • Chart 5 9: Single-Lumen Power-Injectable Implantable Port Market, Europe, 2013 - 2023 389
  • Chart 5 10: Double-Lumen Power-Injectable Implantable Port Market, Europe, 2013 - 2023 391
  • Chart 5 11: Leading Competitors, Implantable Port Market, Europe, 2016 400
  • Chart 6 1: Port Needle Market by Segment, Europe, 2013 - 2023 405
  • Chart 6 2: Port Needle Market Breakdown, Europe, 2016 406
  • Chart 6 3: Port Needle Market Breakdown, Europe, 2023 406
  • Chart 6 4: Total Port Needle Market, Europe, 2013 - 2023 409
  • Chart 6 5: Conventional Port Needle Market, Europe, 2013 - 2023 416
  • Chart 6 6: Safety Port Needle Market, Europe, 2013 - 2023 423
  • Chart 6 7: Power-Injectable Safety Port Needle Market, Europe, 2013 - 2023 430
  • Chart 6 8: Non-Power-Injectable Safety Port Needle Market, Europe, 2013 - 2023 437
  • Chart 6 9: Leading Competitors, Port Needle Market, Europe, 2016 448
  • Chart 7 1: Acute CVC Units Sold by Patient Type, Europe, 2016 455
  • Chart 7 2: Central Venous Catheter Market by Segment, Europe, 2013 - 2023 458
  • Chart 7 3: Central Venous Catheter Market Breakdown, Europe, 2016 459
  • Chart 7 4: Central Venous Catheter Market Breakdown, Europe, 2023 459
  • Chart 7 5: Total Central Venous Catheter Market, Europe, 2013 - 2023 462
  • Chart 7 6: Total Acute Central Venous Catheter Market, Europe, 2013 - 2023 469
  • Chart 7 7: Conventional Acute Central Venous Catheter Market, Europe, 2013 - 2023 476
  • Chart 7 8: Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 - 2023 483
  • Chart 7 9: Chronic Central Venous Catheter Market, Europe, 2013 - 2023 490
  • Chart 7 10: Leading Competitors, Total Central Venous Catheter Market, Europe, 2016 503
  • Chart 7 11: Leading Competitors, Acute Central Venous Catheter Market, Europe, 2016 505
  • Chart 7 12: Leading Competitors, Chronic Central Venous Catheter Market, Europe, 2016 507
  • Chart 8 1: Peripherally Inserted Central Catheter Units Sold by Lumen Number, Europe, 2016 512
  • Chart 8 2: Peripherally Inserted Central Catheter Market by Segment, Europe, 2013 - 2023 515
  • Chart 8 3: Peripherally Inserted Central Catheter Market by Segment, Europe, 2016 516
  • Chart 8 4: Peripherally Inserted Central Catheter Market by Segment, Europe, 2023 516
  • Chart 8 5: Total Peripherally Inserted Central Catheter Market, Europe, 2013 - 2023 519
  • Chart 8 6: Conventional Peripherally Inserted Central Catheter Market, Europe, 2013 - 2023 526
  • Chart 8 7: Power-Injectable Peripherally Inserted Central Catheter Market, Europe, 2013 - 2023 533
  • Chart 8 8: Leading Competitors, Peripherally Inserted Central Catheter Market, Europe, 2016 547
  • Chart 9 1: Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism, Europe, 2016 552
  • Chart 9 2: Peripheral Intravenous Catheter Market by Segment, Europe, 2013 - 2023 556
  • Chart 9 3: Peripheral Intravenous Catheter Market by Segment, Europe, 2016 557
  • Chart 9 4: Peripheral Intravenous Catheter Market by Segment, Europe, 2023 557
  • Chart 9 5: Total Peripheral Intravenous Catheter Market, Europe, 2013 - 2023 560
  • Chart 9 6: Conventional Peripheral Intravenous Catheter Market, Europe, 2013 - 2023 567
  • Chart 9 7: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 - 2023 574
  • Chart 9 8: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 - 2023 582
  • Chart 9 9: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 - 2023 589
  • Chart 9 10: Integrated Blood Control Safety Intravenous Catheter Market, Europe, 2013 - 2023 596
  • Chart 9 11: Total Midline Catheter Market, Europe, 2013 - 2023 603
  • Chart 9 12: Conventional Midline Catheter Market, Europe, 2013 - 2023 605
  • Chart 9 13: Power-Injectable Midline Catheter Market, Europe, 2013 - 2023 607
  • Chart 9 14: All-In-One Midline Catheter Market, Europe, 2013 - 2023 609
  • Chart 9 15: Leading Competitors, Peripheral Intravenous Catheter Market, Europe, 2016 618
  • Chart 10 1: Dialysis Catheter Market by Segment, Europe, 2013 - 2023 625
  • Chart 10 2: Dialysis Catheter Market Breakdown, Europe, 2016 626
  • Chart 10 3: Dialysis Catheter Market Breakdown, Europe, 2023 626
  • Chart 10 4: Total Dialysis Catheter Market, Europe, 2013 - 2023 629
  • Chart 10 5: Acute Hemodialysis Catheter Market, Europe, 2013 - 2023 637
  • Chart 10 6: Total Chronic Hemodialysis Catheter Market, Europe, 2013 - 2023 645
  • Chart 10 7: Conventional Chronic Hemodialysis Catheter Market, Europe, 2013 - 2023 652
  • Chart 10 8: Antimicrobial Chronic Hemodialysis Catheter Market, Europe, 2013 - 2023 660
  • Chart 10 9: Peritoneal Dialysis Catheter Market, Europe, 2013 - 2023 668
  • Chart 10 10: Leading Competitors, Total Dialysis Catheter Market, Europe, 2016 676
  • Chart 10 11: Leading Competitors, Acute Hemodialysis Catheter Market, Europe, 2016 678
  • Chart 10 12: Leading Competitors, Chronic Hemodialysis Catheter Market, Europe, 2016 680
  • Chart 10 13: Leading Competitors, Peritoneal Dialysis Catheter Market, Europe, 2016 681
  • Chart 11 1: Catheter Securement Device Market, Europe, 2013 - 2023 688
  • Chart 11 2: Leading Competitors, Catheter Securement Device Market, Europe, 2016 699
  • Chart 12 1: Syringe and Needle Market by Segment, Europe, 2013 - 2023 705
  • Chart 12 2: Syringe and Needle Market by Segment, Europe, 2016 706
  • Chart 12 3: Syringe and Needle Market by Segment, Europe, 2023 706
  • Chart 12 4: Total Syringe and Needle Market, Europe, 2013 - 2023 709
  • Chart 12 5: Total Syringe Market, Europe, 2013 - 2023 717
  • Chart 12 6: Total Conventional Syringe Market, Europe, 2013 - 2023 725
  • Chart 12 7: Two-Part Conventional Syringe Market, Europe, 2013 - 2023 733
  • Chart 12 8: Three-Part Conventional Syringe Market, Europe, 2013 - 2023 741
  • Chart 12 9: Safety Syringe Market, Europe, 2013 - 2023 749
  • Chart 12 10: Total Insulin Syringe Market, Europe, 2013 - 2023 757
  • Chart 12 11: Insulin Syringe with Needle Market, Europe, 2013 - 2023 764
  • Chart 12 12: Insulin Syringe without Needle Market, Europe, 2013 - 2023 766
  • Chart 12 13: Total Needle Market, Europe, 2013 - 2023 769
  • Chart 12 14: Conventional Needle Market, Europe, 2013 - 2023 777
  • Chart 12 15: Safety Needle Market, Europe, 2013 - 2023 785
  • Chart 12 16: Blunt Type Needle Market, Europe, 2013 - 2023 792
  • Chart 12 17: Leading Competitors, Syringe and Needle Market, Europe, 2016 802
  • Chart 13 1: Ultrasound Vascular Access Device Market, Europe, 2013 - 2023 806

LIST OF FIGURES

For a full figure list, please contact iData Research.

Back to Top